Cardiff Oncology (XE7C) Cash flow

3 Followers

Cardiff Oncology Cash Flow

DE:XE7C's free cash flow for Q2 2026 was $-11.81M. For the 2026 fiscal year, DE:XE7C's free cash flow was decreased by $-194.00K and operating cash flow was $-11.77M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -37.92M	$ -37.69M	$ -30.89M	$ -33.82M	$ -23.04M
Investing Cash Flow	$ 1.34M	$ 13.73M	$ 36.20M	$ 38.15M	$ -131.45M
Financing Cash Flow	$ 2.58M	$ 53.78M	$ 0.00	$ 75.00K	$ 35.45M
End Cash Position	$ 17.47M	$ 51.47M	$ 21.66M	$ 16.35M	$ 11.94M
Free Cash Flow	$ -37.97M	$ -37.77M	$ -31.47M	$ -34.71M	$ -23.25M

Currency in USD